| Ident. | Authors (with country if any) | Title |
|---|
| 000025 |
Frank G. Holz [Allemagne] | [SARS-CoV-2-a challenge for all of us]. |
| 000030 |
Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine] | [Replication and transmission mechanisms of highly pathogenic human coronaviruses]. |
| 000046 |
E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique] | [Coronavirus and COVID-19 : focus on a galopping pandemic]. |
| 000058 |
Zi-Wei Ye [Hong Kong] ; Shuofeng Yuan [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Sin-Yee Fung [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | Zoonotic origins of human coronaviruses |
| 000066 |
Shao-Lun Zhai [République populaire de Chine] ; Wen-Kang Wei [République populaire de Chine] ; Dian-Hong Lv [République populaire de Chine] ; Zhi-Hong Xu [République populaire de Chine] ; Qin-Ling Chen [République populaire de Chine] ; Ming-Fei Sun [République populaire de Chine] ; Feng Li [États-Unis] ; Dan Wang [États-Unis] | Where did SARS-CoV-2 come from? |
| 000083 |
Xiao-Li Qiang ; Peng Xu ; Gang Fang ; Wen-Bin Liu ; Zheng Kou | Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus |
| 000088 |
Yifei Xu [Royaume-Uni] | Unveiling the Origin and Transmission of 2019-nCoV. |
| 000096 |
Mary E. Wilson [États-Unis] ; Lin H. Chen [États-Unis] | Travellers give wings to novel coronavirus (2019-nCoV). |
| 000100 |
Chang-Quan Ling | Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) |
| 000103 |
Shan Lu | Timely development of vaccines against SARS-CoV-2 |
| 000104 |
Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis] | Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond. |
| 000108 |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000116 |
| The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 |
| 000120 |
Kristian G. Andersen [États-Unis] ; Andrew Rambaut [Royaume-Uni] ; W Ian Lipkin [États-Unis] ; Edward C. Holmes [Australie] ; Robert F. Garry [États-Unis] | The proximal origin of SARS-CoV-2. |
| 000124 |
Shajeea Arshad Ali ; Mariam Baloch ; Naseem Ahmed ; Asadullah Arshad Ali ; Ayman Iqbal | The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat |
| 000125 |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
| 000126 |
Carlo Contini [Italie] ; Mariachiara Di Nuzzo [Italie] ; Nicole Barp [Italie] ; Aurora Bonazza [Italie] ; Roberto De Giorgio [Italie] ; Mauro Tognon [Italie] ; Salvatore Rubino [Italie] | The novel zoonotic COVID-19 pandemic: An expected global health concern. |
| 000131 |
Domenico Benvenuto [Italie] ; Marta Giovanetti [Brésil] ; Marco Salemi [États-Unis] ; Mattia Prosperi [États-Unis] ; Cecilia De Flora [Italie] ; Luiz Carlos Junior Alcantara [Brésil] ; Silvia Angeletti [Italie] ; Massimo Ciccozzi [Brésil] | The global spread of 2019-nCoV: a molecular evolutionary analysis |
| 000132 |
Chu-Xia Deng | The global battle against SARS-CoV-2 and COVID-19 |
| 000133 |
Marta Giovanetti [Brésil] ; Domenico Benvenuto [Italie] ; Silvia Angeletti [Italie] ; Massimo Ciccozzi [Italie] | The first two cases of 2019-nCoV in Italy: Where they come from? |
| 000136 |
Hussin A. Rothan [États-Unis] ; Siddappa N. Byrareddy [États-Unis] | The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak |
| 000143 |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
| 000147 |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. |
| 000159 |
Parham Habibzadeh ; Emily K. Stoneman [États-Unis] | The Novel Coronavirus: A Bird's Eye View. |
| 000175 |
Thirumalaisamy P. Velavan [Allemagne] ; Christian G. Meyer [Allemagne] | The COVID-19 epidemic. |
| 000178 |
Domenico Benvenuto [Italie] ; Marta Giovanetti [Brésil] ; Alessandra Ciccozzi [Italie] ; Silvia Spoto [Italie] ; Silvia Angeletti [Italie] ; Massimo Ciccozzi [Brésil] | The 2019-new coronavirus epidemic: Evidence for virus evolution. |
| 000184 |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
| 000188 |
Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian Guo | Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |
| 000199 |
Jian Shang [États-Unis] ; Yushun Wan [États-Unis] ; Chang Liu [États-Unis] ; Boyd Yount [États-Unis] ; Kendra Gully [États-Unis] ; Yang Yang [États-Unis] ; Ashley Auerbach [États-Unis] ; Guiqing Peng [République populaire de Chine] ; Ralph Baric [États-Unis] ; Fang Li [États-Unis] | Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. |
| 000207 |
Suhas Srinivasan [États-Unis] ; Hongzhu Cui [États-Unis] ; Ziyang Gao [États-Unis] ; Ming Liu [États-Unis] ; Senbao Lu [États-Unis] ; Winnie Mkandawire [États-Unis] ; Oleksandr Narykov [États-Unis] ; Mo Sun [États-Unis] ; Dmitry Korkin [États-Unis] | Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins. |
| 000218 |
Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
| 000222 |
Kun Li [États-Unis] ; Zhuo Li [États-Unis] ; Christine Wohlford-Lenane [États-Unis] ; David K. Meyerholz [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Dong An [États-Unis] ; Stanley Perlman [États-Unis] ; Paul B. Mccray [États-Unis] ; Biao He [États-Unis] | Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection |
| 000258 |
Jun Zheng [République populaire de Chine] | SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat |
| 000296 |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity |
| 000303 |
Lisa E. Gralinski ; Vineet D. Menachery [États-Unis] | Return of the Coronavirus: 2019-nCoV |
| 000316 |
Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. |
| 000328 |
Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis] | Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. |
| 000356 |
Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz Feldmann | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |
| 000367 |
Tao Zhang [République populaire de Chine] ; Qunfu Wu [République populaire de Chine] ; Zhigang Zhang [République populaire de Chine] | Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. |
| 000392 |
Isaac I. Bogoch [Canada] ; Alexander Watts [Canada] ; Andrea Thomas-Bachli [Canada] ; Carmen Huber [Canada] ; Moritz U G. Kraemer [Royaume-Uni] ; Kamran Khan [Canada] | Potential for global spread of a novel coronavirus from China. |
| 000399 |
Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis] | Potential Factors Influencing Repeated SARS Outbreaks in China |
| 000410 |
Isaac I. Bogoch [Canada] ; Alexander Watts [Canada] ; Andrea Thomas-Bachli [Canada] ; Carmen Huber [Canada] ; Moritz U G. Kraemer [Royaume-Uni] ; Kamran Khan [Canada] | Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. |
| 000451 |
Shan-Lu Liu [États-Unis] ; Linda J. Saif [États-Unis] ; Susan R. Weiss [États-Unis] ; Lishan Su [États-Unis] | No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 |
| 000463 |
Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000512 |
Sarah E. Henrickson [États-Unis] | Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2? |
| 000541 |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000580 |
Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
| 000602 |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 000619 |
Michael Letko [États-Unis] ; Andrea Marzi [États-Unis] ; Vincent Munster [États-Unis] | Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. |
| 000663 |
Jianhui Nie [République populaire de Chine] ; Qianqian Li [République populaire de Chine] ; Jiajing Wu [République populaire de Chine] ; Chenyan Zhao [République populaire de Chine] ; Huan Hao [République populaire de Chine] ; Huan Liu [République populaire de Chine] ; Li Zhang [République populaire de Chine] ; Lingling Nie [République populaire de Chine] ; Haiyang Qin [République populaire de Chine] ; Meng Wang [République populaire de Chine] ; Qiong Lu [République populaire de Chine] ; Xiaoyu Li [République populaire de Chine] ; Qiyu Sun [République populaire de Chine] ; Junkai Liu [République populaire de Chine] ; Changfa Fan [République populaire de Chine] ; Weijin Huang [République populaire de Chine] ; Miao Xu [République populaire de Chine] ; Youchun Wang [République populaire de Chine] | Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 |
| 000664 |
David M. Morens ; Peter Daszak ; Jeffery K. Taubenberger | Escaping Pandora's Box - Another Novel Coronavirus. |
| 000675 |
Shutoku Matsuyama [Japon] ; Naganori Nao [Japon] ; Kazuya Shirato [Japon] ; Miyuki Kawase [Japon] ; Shinji Saito [Japon] ; Ikuyo Takayama [Japon] ; Noriyo Nagata [Japon] ; Tsuyoshi Sekizuka [Japon] ; Hiroshi Katoh [Japon] ; Fumihiro Kato [Japon] ; Masafumi Sakata [Japon] ; Maino Tahara [Japon] ; Satoshi Kutsuna [Japon] ; Norio Ohmagari [Japon] ; Makoto Kuroda [Japon] ; Tadaki Suzuki [Japon] ; Tsutomu Kageyama [Japon] ; Makoto Takeda [Japon] | Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. |
| 000678 |
Yashpal Singh Malik [Inde] ; Shubhankar Sircar [Inde] ; Sudipta Bhat [Inde] ; Khan Sharun [Inde] ; Kuldeep Dhama [Inde] ; Maryam Dadar [Iran] ; Ruchi Tiwari [Inde] ; Wanpen Chaicumpa [Thaïlande] | Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments |
| 000720 |
Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. |
| 000721 |
Bei Li [République populaire de Chine] ; Hao-Rui Si [République populaire de Chine] ; Yan Zhu [République populaire de Chine] ; Xing-Lou Yang [République populaire de Chine] ; Danielle E. Anderson [Singapour] ; Zheng-Li Shi [République populaire de Chine] ; Lin-Fa Wang [Singapour] ; Peng Zhou [République populaire de Chine] | Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing |
| 000739 |
Marc T. Valitutto [États-Unis] ; Ohnmar Aung [États-Unis] ; Kyaw Yan Naing Tun [États-Unis] ; Megan E. Vodzak [États-Unis] ; Dawn Zimmerman [États-Unis] ; Jennifer H. Yu [États-Unis] ; Ye Tun Win [Birmanie] ; Min Thein Maw [Birmanie] ; Wai Zin Thein [Birmanie] ; Htay Htay Win [Birmanie] ; Jasjeet Dhanota [États-Unis] ; Victoria Ontiveros [États-Unis] ; Brett Smith [États-Unis] ; Alexandre Tremeau-Brevard [États-Unis] ; Tracey Goldstein [États-Unis] ; Christine K. Johnson [États-Unis] ; Suzan Murray [États-Unis] ; Jonna Mazet [États-Unis] | Detection of novel coronaviruses in bats in Myanmar |
| 000747 |
Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
| 000774 |
Daniela Ruffell | Coronavirus SARS‐CoV‐2: filtering fact from fiction in the infodemic |
| 000779 |
Ahmed Al-Mandhari [Égypte] ; Dalia Samhouri [Égypte] ; Abdinasir Abubakar [Égypte] ; Richard Brennan [Égypte] | Coronavirus Disease 2019 outbreak: preparedness and readiness of countries in the Eastern Mediterranean Region. |
| 000795 |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
| 000881 |
Ivan Seah [Singapour] ; Rupesh Agrawal [Singapour, Royaume-Uni] | Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals |
| 000891 |
Ye Yi ; Philip N. P. Lagniton ; Sen Ye ; Enqin Li ; Ren-He Xu | COVID-19: what has been learned and to be learned about the novel coronavirus disease |
| 000913 |
Andrew M. South [États-Unis] ; Debra I. Diz [États-Unis] ; Mark C. Chappell [États-Unis] | COVID-19, ACE2, and the cardiovascular consequences. |
| 000958 |
S. Kannan [Maldives] ; P. Shaik Syed Ali ; A. Sheeza ; K. Hemalatha | COVID-19 (Novel Coronavirus 2019) - recent trends. |
| 000987 |
Catherine S. Adamson [Royaume-Uni] | Antiviral Agents: Discovery to Resistance. |
| 000A18 |
Sin-Yee Fung [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Zi-Wei Ye [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
| 000A25 |
Hong-Ying Li [États-Unis] ; Guang-Jian Zhu [États-Unis] ; Yun-Zhi Zhang [République populaire de Chine] ; Li-Biao Zhang [République populaire de Chine] ; Emily A. Hagan [États-Unis] ; Stephanie Martinez [États-Unis] ; Aleksei A. Chmura [États-Unis] ; Leilani Francisco [États-Unis] ; Hina Tai [États-Unis] ; Maureen Miller [États-Unis] ; Peter Daszak [États-Unis] | A qualitative study of zoonotic risk factors among rural communities in southern China. |
| 000A28 |
Peng Zhou [République populaire de Chine] ; Xing-Lou Yang [République populaire de Chine] ; Xian-Guang Wang [République populaire de Chine] ; Ben Hu [République populaire de Chine] ; Lei Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Hao-Rui Si [République populaire de Chine] ; Yan Zhu [République populaire de Chine] ; Bei Li [République populaire de Chine] ; Chao-Lin Huang [République populaire de Chine] ; Hui-Dong Chen [République populaire de Chine] ; Jing Chen [République populaire de Chine] ; Yun Luo [République populaire de Chine] ; Hua Guo [République populaire de Chine] ; Ren-Di Jiang [République populaire de Chine] ; Mei-Qin Liu [République populaire de Chine] ; Ying Chen [République populaire de Chine] ; Xu-Rui Shen [République populaire de Chine] ; Xi Wang [République populaire de Chine] ; Xiao-Shuang Zheng [République populaire de Chine] ; Kai Zhao [République populaire de Chine] ; Quan-Jiao Chen [République populaire de Chine] ; Fei Deng [République populaire de Chine] ; Lin-Lin Liu [République populaire de Chine] ; Bing Yan [République populaire de Chine] ; Fa-Xian Zhan [République populaire de Chine] ; Yan-Yi Wang [République populaire de Chine] ; Geng-Fu Xiao [République populaire de Chine] ; Zheng-Li Shi [République populaire de Chine] | A pneumonia outbreak associated with a new coronavirus of probable bat origin |
| 000A32 |
Tian-Mu Chen ; Jia Rui ; Qiu-Peng Wang ; Ze-Yu Zhao ; Jing-An Cui [République populaire de Chine] ; Ling Yin | A mathematical model for simulating the phase-based transmissibility of a novel coronavirus |
| 000A57 |
T M Wassenaar [Allemagne] ; Y. Zou [République populaire de Chine] | 2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses. |
| 000A60 |
Robyn Ralph [Canada] ; Jocelyne Lew [Canada] ; Tiansheng Zeng [République populaire de Chine] ; Magie Francis [Canada] ; Bei Xue [République populaire de Chine] ; Melissa Roux [Canada] ; Ali Toloue Ostadgavahi [Canada] ; Salvatore Rubino [Italie] ; Nicholas J. Dawe [Canada] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; David J. Kelvin [République populaire de Chine] ; Christopher D. Richardson [Canada] ; Jason Kindrachuk [Canada] ; Darryl Falzarano [Canada] ; Alyson Anne Kelvin [Canada] | 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. |
| 000A68 |
Kozue Shimabukuro [Japon] ; Makoto Ujike ; Toshihiro Ito ; Hiroshi Tsunemitsu ; Hitoshi Oshitani ; Fumihiro Taguchi | Hemagglutination mediated by the spike protein of cell-adapted bovine torovirus. |
| 000A72 |
Christel Schwegmann-Wessels [Allemagne] ; Sandra Bauer ; Christine Winter ; Luis Enjuanes ; Hubert Laude ; Georg Herrler | The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus. |
| 000A76 |
Kristin C. Halfpenny [États-Unis] ; David W. Wright [États-Unis] | Nanoparticle detection of respiratory infection |
| 000A84 |
Purnima Kumar [Inde] ; Vithiagaran Gunalan ; Boping Liu ; Vincent T K. Chow ; Julian Druce ; Chris Birch ; Mike Catton ; Burtram C. Fielding ; Yee-Joo Tan ; Sunil K. Lal | The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein. |
| 000A85 |
| Ranpirnase: amphibian ribonuclease A, P-30 protein-alfacell. |
| 000A87 |
Jan Balzarini [Belgique] | Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? |
| 000A90 |
Roberta Scipioni Ball [États-Unis] | Issues to consider for preparing ferrets as research subjects in the laboratory. |
| 000A93 |
J. L. Heeney [Pays-Bas] | Zoonotic viral diseases and the frontier of early diagnosis, control and prevention |
| 000B14 |
Mahdi Asghari Ozma [Iran] ; Parham Maroufi [Iran] ; Ehsaneh Khodadadi [Iran] ; Kran Köse [Turquie] ; Isabella Esposito [Italie] ; Khudaverdi Ganbarov ; Sounkalo Dao [Mali] ; Silvano Esposito [Italie] ; Tuba Dal [Turquie] ; Elham Zeinalzadeh [Iran] ; Hossein Samadi Kafil [Iran] | Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. |
